Combination therapy for diabetes, obesity, and cardiovascular diseases using GDF-8 inhibitors

Details for Australian Patent Application No. 2005272646 (hide)

Owner Wyeth

Inventors Tobin, James F.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005272646

PCT Pub. Number WO2006/020884

Priority 60/600,784 12.08.04 US

Filing date 11 August 2005

Wipo publication date 23 February 2006

International Classifications

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

8 March 2007 PCT application entered the National Phase

  PCT publication WO2006/020884 Priority application(s): WO2006/020884

2 July 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005272647-Process for the preparation of 3-oximino steroids

2005272636-Systems and methods for remotely controlling computer applications